Treating Cancer in a FLASH: the Future of Radiotherapy with Dr. Bill Loo
Join us as we explore groundbreaking advancements in cancer treatment with Dr. Bill Loo from Stanford University. Discover how TibaRay's innovative radiotherapy technology is transforming the landscape of cancer care, offering faster, more precise treatments with fewer side effects. Learn about the potential of FLASH therapy and its implications for treating not only cancer but other diseases as well. Don't miss this insightful discussion on the future of medical technology. #CancerTreatment #Radiotherapy #MedicalInnovation #FLASHtherapy #TibaRay
Bill Loo is a physician-scientist Radiation Oncologist and Bioengineer, and Professor of Radiation Oncology at Stanford University School of Medicine. He serves as Director of Thoracic Radiation Oncology, Co-Director of Particle Therapy, and Director of New Technologies in Radiation Oncology at Stanford Cancer Institute. His clinical expertise is in state-of-the-art radiation therapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR) and 4-D image-guided radiation therapy.
He is an internationally recognized expert on thoracic cancers and radiotherapy and serves on expert panels of the National Comprehensive Cancer Network that produce among the most widely adopted clinical practice guidelines for cancer. His clinical research is in clinical trials and implementation of new treatment techniques for lung cancer and development of new medical imaging and other biomarkers. He is principal investigator of a research lab recognized as a global leader in the biology of ultra-rapid FLASH radiotherapy and development of next generation radiation technologies to deliver FLASH.
Bill conceived of the revolutionary PHASER concept for highly conformal FLASH cancer therapy and serves as co-leader of its research and development. He is a co-founder, board member, and Chief Medical Advisor of TibaRay where this technology is being brought to practical reality.
Bill received his MD from University of California, Davis and his PhD in Bioengineering from University of California, San Francisco and Berkeley. He completed his Radiation Onc…Read More